N-myc downstream-regulated gene 1 promotes oxaliplatintriggered apoptosis in colorectal cancer cells via enhancing the ubiquitination of Bcl-2

SUPPLEMENTARY FIGURES AND TABLE
Supplementary Figure 1: (A)
Western blots showing protein levels of several apoptosis regulating factors namely NDRG1, Bcl-2, Puma, BID, and death receptor 5 (DR5) in selected patients from no-downstaging and downstaging group respectively.
(B, C) Quantitative analysis of protein levels showed in Figure. 2C (B) and 2D (C). Red line indicated comparison between drug-treated and -untreated groups. Data were from three independent experiments. Bars indicated SD. NS, not significant, *, P < 0.05, **, P < 0.01. Transfects were then cultured in medium containing oxaliplatin (15μM). Apoptosis were analyzed with flow cytometry assay. The successful transfection of Bcl-2 and NDRG1 were confirmed by western blots. Densitometry showed relative protein expression normalized for GAPDH. (E) PKCβ status had no effect on the stablity of Bcl-2 or apoptosis. HCT116 cells were transfected with PKCβ, shPKCβ or control vector. Protein level of Bcl-2 was then detected with western blot. (F) NDRG1 was unable to modulate mRNA level of PKCα. After transfection of NDRG1 constructs or control vector (10μg), total RNA was extracted and subjected to RT-PCR. (G) Quantitative analysis of IHC scores of Figure. 6D. Red line indicated comparison between drug-treated and -untreated groups. Histograms showed mean values from three independent experiments; bars indicated SD; NS, not significant, *, P < 0.05, **, P < 0.01.
